News

President Joe Biden has proposed expanding Medicare and Medicaid coverage for anti-obesity drugs, potentially reducing out-of-pocket costs for millions by up to 95%. This move aims to make weight loss medications more accessible, helping to prevent type 2 diabetes and reduce the risk of heart attacks and death, though it faces potential challenges from both political opponents and the pharmaceutical industry.

A network of proteins found in the central nervous system could be harnessed to increase the effectiveness and reduce the side effects of popular diabetes and weight
loss drugs, according to new research.

In recent times, the allure of quick weight loss solutions has escalated, catching the attention of not just individuals battling

A new artificial intelligence model finds that x-ray images collected during routine medical care can provide warning signs for diabetes, even in patients who don’t meet the guidelines for elevated risk. The model could help physicians detect the disease earlier and prevent complications, says a multi-institutional team which published the findings in Nature Communications.

A newly published study from York University sheds light on the biological underpinnings in sex differences in obesity-related disease, with researchers observing “striking” differences in the cells that build blood vessels in the fatty tissue of male versus female mice.